Fund moves
35 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
VTR · NYSE · Health Care REITs
Ventas (VTR) · oqro.io/stocks/VTR · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$86.55−0.45 (−0.52%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
No open-market purchase by an insider of Ventas was filed in the last 90 days. The latest on record was on Jun 5, 2026.
Since 2006, Ventas insiders reported 6 open-market purchases and 2,570 sales on Forms 4 and 5, with purchases in 4 different years, most recently 2026.
No open-market sale by an insider of Ventas (VTR) was filed with the SEC in the last 90 days.
Yes. Members of Congress disclosed 3 trades in Ventas (VTR) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent are from Sen. Alan Armstrong, Rep. Gilbert Ray Cisneros Jr. (CA31).
Ventas's next results are expected on Feb 3, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
+8.5% (+$6.77) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $79.78 on Nov 20, 2025 to $86.55 on Nov 20, 2026 (+8.5%). Disclosed in this range: 2 insider trades, 6 pre-arranged insider sales, 2 Congress trades, and 50 13F position changes for 3 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care REITs company based in Chicago, Illinois.
Last 12 months
+8.5%
Market value
$45.8B
S&P 500 +5.7% over the same dates. Prices adjusted for splits and dividends.
Short interest: 15M shares sold short (2.8% of shares outstanding), +3.6% vs the previous count, 4.0 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
Revenue, fiscal 2025
$5.83B
+18.5% vs the year before
Net income
Not reported
As reported in the annual filing
Shares outstanding
529M
As of Oct 27, 2026
In fiscal 2025 the company spent $860M on dividends. Cash actually paid, from its cash-flow statement.
Fund moves
35 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
14 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
35 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
35 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Revenue
$1.83B
+23.0% vs the same quarter a year earlier
Free cash flow, last 12 months
—
Cash from operations minus capital spending
Net debt
—
Debt —, cash $202M, at Sep 30, 2026
Net income, last 12 months
—
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 27, 2026.
Revenue and earnings history, 19 fiscal yearsRevenue breakdown: where the money goesCompared with its peersEarnings dates and the stock's moves
Against the S&P 500 over the year
Since Nov 19, 2025, VTR is up 8.2% and the index fund is up 4.1%: 4 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much VTR moves
Beta −0.1 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).
On the public record for Ventas over the 12 months to Nov 21, 2026: 4 executive contributions.
Insiders of Ventas reported 6 open-market purchases and 2,570 sales since 2006; purchases in 4 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $197K1×1 trade | $7.88M6×6 trades |
| 2025 | — | $99.5M50×50 trades |
| 2024 | — | $27.3M24×24 trades |
| 2023 | — | $1.82M3×3 trades |
| 2022 | — | $9.4M5×5 trades |
| 2021 | — | $9.84M15×15 trades |
| 2020 | — | $6.01M5×5 trades |
| 2019 | — | $19.2M14×14 trades |
| 2018 | — | $8.8M9×9 trades |
| 2017 | — | $17.7M9×9 trades |
| 2016 | — | $18.7M14×14 trades |
| 2015 | — | $11.4M9×9 trades |
| 2014 | — | $43.8M12×12 trades |
| 2013 | $580K1×1 trade | $11M8×8 trades |
| 2012 | $139K2×2 trades | $3.43B26×26 trades |
| 2011 | — | $18.6M13×13 trades |
| 2010 | — | $24.1M357×357 trades |
| 2009 | — | $7.62M134×134 trades |
| 2008 | — | $14.2M710×710 trades |
| 2007 | $71K2×2 trades | $16.5M706×706 trades |
| 2006 | — | $15.4M441×441 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
JPMORGAN CHASE & CO.
13G · passive · Up from 7.1% · 42.6M shares · filed Jul 27, 2026
Vanguard Portfolio Management
13G · passive · Crossed 5% · 41.3M shares · filed Apr 29, 2026
Vanguard Capital Management
13G · passive · Crossed 5% · 35.9M shares · filed Apr 30, 2026
Recent moves
JPMORGAN CHASE & CO. raised its stake to 8.7% from 7.1% · Schedule 13G, 2026
JPMORGAN CHASE & CO. raised its stake to 7.1% from 5.9% · Schedule 13G, 2026
Vanguard Capital Management went above 5%, with 7.55% · Schedule 13G, 2026
Vanguard Portfolio Management went above 5%, with 8.69% · Schedule 13G, 2026
The Vanguard Group fell below 5% (0%) · Schedule 13G, 2026
JPMORGAN CHASE & CO. went above 5%, with 5.9% · Schedule 13G, 2026
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Top officer leaving
“…and President and CEO, Lillibridge Healthcare Services, Inc., is expected to retire effective as of May 1, 2026 (the “Effective Date”).”
3 insiders sold ~$47.1M in the 60 days before
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
Congress
Funds and stakes
Contracts, lobbying and filings
Company reports, price and press
Who holds it
Attention
Things to keep in mind
Records
Last results
Oct 27, 2026
Within the 30 days after it, until Nov 26, 2026
Next results, expected
Feb 3, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
Not enough history
From Ventas's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Ventas's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
People read Ventas's Wikipedia article about 12 times a day over the last week, close to the 15 on a usual day of the three months before.
May 16, 2026Busiest day: 49 views on Jul 9, 2026Nov 21, 2026
Views of the article Ventas (company), by people (Wikimedia leaves out known bots). More readers means more attention, from news, results or anything else; it does not say anyone bought or sold. Source: Wikimedia pageviews.
Short sale volume: 56.7% of the volume reported to FINRA over the last 20 trading days was marked short, close to its 1-year average of 57.5%. FINRA daily files, to Nov 20, 2026.
Fails to deliver: 35K shares (about $3.05M) were not delivered on time for settlement on Oct 23, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
Off-exchange trading: 41.1% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (25.9% on ATS, 15.2% with other brokers), close to its 26-week average of 40.9%. Weeks of Oct 5 to Oct 30, 2026.
Largest ATS: UBS ATS (13.7%), INTELLIGENT CROSS LLC (12.0%), SIGMA X2 (8.2%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
Latest annual report filed Feb 6, 2026, compared with the one filed Feb 13, 2025. Read the filing
The information contained in “Note 14 – Commitments and Contingencies” of the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report is incorporated by reference into this Item 3. Except as set forth therein, we are not a party to, nor is any of our property the subject of, any material pending legal proceedings.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 6, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
Fiscal year Jan 1, 2025 to Dec 31, 2025, from the annual report filed Feb 6, 2026. Read the filing
+27% on the year before ($3.37B)
+2.3% on the year before ($878M)
−3.3% on the year before ($622M)
The segments reach the total once $58.3M of items outside them is counted: corporate items, and the removal of sales between segments so they are not counted twice, as the company reports them.
+19% on the year before ($4.37B)
+5.0% on the year before ($527M)
+132% on the year before ($30.7M)
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 16,000 words.
We elected to be taxed as a real estate investment trust (“REIT”) under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the “Code”), commencing with our taxable year ended December 31, 1999. Provided we qualify for taxation as a REIT, we generally are not required to pay U.S. federal corporate income taxes on our REIT taxable income that is currently distributed to our stockholders. In order to maintain our qualification as a REIT, we must satisfy a number of technical requirements, which impact how we invest in, operate and manage our assets. See “Risk Factors—Risks Relating to Our REIT Status” included in Part I, Item 1A of this Annual Report.
And 26 more headings in the filing.
Source: SEC EDGAR, Form 10-K filed Feb 6, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.